Post by Zach Henderson

Happy to share that I've joined MindMaze Therapeutics as CEO. Since its founding, MindMaze Therapeutics has: 1. Invested heavily to build the leading precision neurotherapeutics platform treating the entire patient journey from Inpatient to Outpatient to Home. 2. Achieved Class II regulatory approval across the US, Europe and the Middle East. 3. Established comprehensive clinical evidence in both #RCT and #RWE studies. Our focus now is the final phase for any healthcare company: accelerating our existing commercial footprint with a particular focus on U.S. market expansion. We will continue to build partnerships with health systems, life science companies and the broader neurology community as we expand the use of the MindMaze product portfolio around the world. Grateful for the opportunity to work alongside Alexandre Capet, Jeremy Meinen and the talented #MindMaze Therapeutics team. For more information, please visit https://lnkd.in/gw-eYFST.